DETAILED NOTES ON LINK ALTERNATIF MBL77

Whereas reduced-rely MBL rarely progresses to CLL, high-rely MBL progresses to CLL requiring therapy at a rate of one% to 2% per year. Superior-rely MBL is distinguished from Rai 0 CLL determined by whether the B-cell count is earlier mentioned or underneath five × 109/L. While people today with each substantial-depend MBL and CLL Rai stage 0 are